Healing an ailing pharmaceutical system: prescription for reform for United States and Canada

BMJ. 2018 May 17:361:k1039. doi: 10.1136/bmj.k1039.

Authors

Adam Gaffney¹, Joel Lexchin²; US; Canadian Pharmaceutical Policy Reform Working Group

Affiliations

¹ Department of Medicine, Cambridge Hospital/Harvard Medical School, Cambridge, MA 02139, USA agaffney@challiance.org.
² School of Health Policy and Management, York University, Toronto, Ontario, Canada.

PMID: 29773533
DOI: 10.1136/bmj.k1039

No abstract available

Publication types

Review

MeSH terms

Canada
Drug Costs
Drug Industry / economics
Drug Industry / organization & administration*
Financing, Government*
Health Care Reform* / economics
Humans
Insurance, Pharmaceutical Services / economics*
Organizational Innovation
Pharmaceutical Services / economics
Pharmaceutical Services / organization & administration*
Pharmaceutical Services / standards
Prescription Drugs / economics*
United States
Universal Health Insurance / economics
Universal Health Insurance / organization & administration

Substances

Prescription Drugs